• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于所有术前风险类别,外科医生的经验与前列腺癌根治术后的生化复发密切相关。

Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.

作者信息

Klein Eric A, Bianco Fernando J, Serio Angel M, Eastham James A, Kattan Michael W, Pontes J Edson, Vickers Andrew J, Scardino Peter T

机构信息

Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

J Urol. 2008 Jun;179(6):2212-6; discussion 2216-7. doi: 10.1016/j.juro.2008.01.107. Epub 2008 Apr 18.

DOI:10.1016/j.juro.2008.01.107
PMID:18423716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3567913/
Abstract

PURPOSE

We have previously reported that there is a learning curve for open radical prostatectomy. In the current study we determined whether the effects of the learning curve are modified by patient risk, as defined by preoperative tumor characteristics.

MATERIALS AND METHODS

The study included 7,683 eligible patients with prostate cancer treated with open radical prostatectomy by 1 of 72 surgeons. Surgeon experience was coded as the total prior number of radical prostatectomies done by the surgeon before a patient surgery. Multivariate survival time regression models were used to evaluate the association between surgeon experience and biochemical recurrence separately in each preoperative risk group.

RESULTS

We saw no evidence that patient risk affected the learning curve. There was a statistically significant association between biochemical recurrence and surgeon experience on all analyses. The absolute risk difference in a patient receiving treatment from a surgeon with 10 vs 250 prior radical prostatectomies was 6.6% (95% CI 3.4-10.3), 12.0% (95% CI 6.9-18.2) and 9.7% (95% CI 1.2-18.2) in patients at low, medium and high preoperative risk. Recurrence-free probability in patients with low risk disease approached 100% for the most experienced surgeons.

CONCLUSIONS

Cancer control after radical prostatectomy improves with increasing surgeon experience irrespective of patient risk. Excellent rates of cancer control in patients with low risk disease treated by the most experienced surgeons suggest that the primary reason that recurrence develops in such patients is inadequate surgical technique. The results have significant implications for clinical care.

摘要

目的

我们之前报道过开放性根治性前列腺切除术存在学习曲线。在本研究中,我们确定术前肿瘤特征所定义的患者风险是否会改变学习曲线的影响。

材料与方法

该研究纳入了7683例符合条件的前列腺癌患者,由72名外科医生中的1名进行开放性根治性前列腺切除术。外科医生的经验编码为该外科医生在患者手术前完成的根治性前列腺切除术的总例数。多变量生存时间回归模型用于分别评估每个术前风险组中外科医生经验与生化复发之间的关联。

结果

我们没有发现患者风险影响学习曲线的证据。在所有分析中,生化复发与外科医生经验之间存在统计学上的显著关联。术前低、中、高风险患者中,接受过10例与250例既往根治性前列腺切除术的外科医生治疗的患者,其绝对风险差异分别为6.6%(95%CI 3.4 - 10.3)、12.0%(95%CI 6.9 - 18.2)和9.7%(95%CI 1.2 - 18.2)。对于经验最丰富的外科医生,低风险疾病患者的无复发生存概率接近100%。

结论

无论患者风险如何,随着外科医生经验的增加,根治性前列腺切除术后的癌症控制情况会得到改善。经验最丰富的外科医生治疗的低风险疾病患者的癌症控制率极高,这表明此类患者复发的主要原因是手术技术不足。这些结果对临床护理具有重要意义。

相似文献

1
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.对于所有术前风险类别,外科医生的经验与前列腺癌根治术后的生化复发密切相关。
J Urol. 2008 Jun;179(6):2212-6; discussion 2216-7. doi: 10.1016/j.juro.2008.01.107. Epub 2008 Apr 18.
2
The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve Study.经验对机器人辅助根治性前列腺切除术后手术切缘和生化复发风险的影响:学习曲线研究。
J Urol. 2019 Jul;202(1):108-113. doi: 10.1097/JU.0000000000000147. Epub 2019 Jun 7.
3
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.病理分期对根治性前列腺切除术学习曲线的影响:器官局限性癌症复发很大程度上与手术技术不充分相关的证据。
Eur Urol. 2008 May;53(5):960-6. doi: 10.1016/j.eururo.2008.01.005. Epub 2008 Jan 14.
4
The surgical learning curve for prostate cancer control after radical prostatectomy.根治性前列腺切除术后控制前列腺癌的手术学习曲线。
J Natl Cancer Inst. 2007 Aug 1;99(15):1171-7. doi: 10.1093/jnci/djm060. Epub 2007 Jul 24.
5
The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study.腹腔镜根治性前列腺切除术的手术学习曲线:一项回顾性队列研究。
Lancet Oncol. 2009 May;10(5):475-80. doi: 10.1016/S1470-2045(09)70079-8. Epub 2009 Apr 1.
6
Variations among experienced surgeons in cancer control after open radical prostatectomy.经验丰富的外科医生在开放性根治性前列腺切除术后癌症控制方面的差异。
J Urol. 2010 Mar;183(3):977-82. doi: 10.1016/j.juro.2009.11.015. Epub 2010 Jan 18.
7
The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point.开放根治性前列腺切除术切缘学习曲线:切缘状态作为肿瘤学终点的意义。
J Urol. 2010 Apr;183(4):1360-5. doi: 10.1016/j.juro.2009.12.015. Epub 2010 Feb 19.
8
The learning curve for laparoscopic radical prostatectomy: an international multicenter study.腹腔镜根治性前列腺切除术的学习曲线:一项国际多中心研究。
J Urol. 2010 Dec;184(6):2291-6. doi: 10.1016/j.juro.2010.08.003. Epub 2010 Oct 16.
9
Assessing the Impact of Surgeon Experience on Urinary Continence Recovery After Robot-Assisted Radical Prostatectomy: Results of Four High-Volume Surgeons.评估外科医生经验对机器人辅助根治性前列腺切除术后尿失禁恢复的影响:四位高手术量外科医生的研究结果。
J Endourol. 2017 Sep;31(9):872-877. doi: 10.1089/end.2017.0085. Epub 2017 Jul 21.
10
Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.机器人辅助根治性前列腺切除术后生化复发的危险因素:单中心经验
BMC Urol. 2015 Apr 8;15:27. doi: 10.1186/s12894-015-0024-7.

引用本文的文献

1
Clinical Predictors and Risk Factors of Gleason Score Upgrade: A Retrospective Cohort Analysis.Gleason评分升级的临床预测因素和风险因素:一项回顾性队列分析
Diagnostics (Basel). 2025 May 14;15(10):1238. doi: 10.3390/diagnostics15101238.
2
Impact of Nerve-Sparing Techniques on Prostate-Specific Antigen Persistence Following Robot-Assisted Radical Prostatectomy: A Multivariable Analysis of Clinical and Pathological Predictors.保留神经技术对机器人辅助根治性前列腺切除术后前列腺特异性抗原持续存在的影响:临床和病理预测因素的多变量分析
Diagnostics (Basel). 2025 Apr 13;15(8):987. doi: 10.3390/diagnostics15080987.
3
Urinary continence outcomes, surgical margin status, and complications after radical prostatectomy in 2,141 German patients treated in one high-volume inpatient rehabilitation clinic in 2022.

本文引用的文献

1
Pathologic stage migration has slowed in the late PSA era.在前列腺特异性抗原(PSA)检测时代后期,病理分期的进展已经放缓。
Urology. 2007 Nov;70(5):839-42. doi: 10.1016/j.urology.2007.09.001.
2
The surgical learning curve for prostate cancer control after radical prostatectomy.根治性前列腺切除术后控制前列腺癌的手术学习曲线。
J Natl Cancer Inst. 2007 Aug 1;99(15):1171-7. doi: 10.1093/jnci/djm060. Epub 2007 Jul 24.
3
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
2022 年,在一家高容量住院康复诊所中,对 2141 名德国患者进行了根治性前列腺切除术,评估了他们的尿控结局、手术切缘状态和并发症。
World J Urol. 2024 Aug 22;42(1):494. doi: 10.1007/s00345-024-05200-0.
4
The role of ischaemia-reperfusion injury and liver regeneration in hepatic tumour recurrence.缺血再灌注损伤和肝再生在肝肿瘤复发中的作用。
JHEP Rep. 2023 Jul 11;5(11):100846. doi: 10.1016/j.jhepr.2023.100846. eCollection 2023 Nov.
5
Learning curve for robot-assisted laparoscopic radical prostatectomy in a large prospective multicentre study.机器人辅助腹腔镜根治性前列腺切除术的学习曲线:一项大型前瞻性多中心研究。
Scand J Urol. 2022 Jun;56(3):182-190. doi: 10.1080/21681805.2022.2070274. Epub 2022 May 12.
6
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value.根治性前列腺切除术后根据前列腺特异性抗原最低点值的生化复发。
PLoS One. 2021 May 3;16(5):e0249709. doi: 10.1371/journal.pone.0249709. eCollection 2021.
7
Current status of uro-oncology training during urology residency and the need for fellowship programs: An international questionnaire study.泌尿外科住院医师培训期间尿路上皮肿瘤学培训的现状及对专科 fellowship 项目的需求:一项国际问卷调查研究
Turk J Urol. 2020 Nov;46(6):455-459. doi: 10.5152/tud.2020.20276. Epub 2020 Oct 21.
8
Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy.对于接受机器人辅助根治性前列腺切除术并达到前列腺特异性抗原无法检测水平的高危前列腺癌患者,疾病复发时间是转移和死亡的预测指标。
J Korean Med Sci. 2018 Oct 16;33(45):e285. doi: 10.3346/jkms.2018.33.e285. eCollection 2018 Nov 5.
9
Does tumour effraction during robotic partial nephrectomy have any impact on recurrence?机器人辅助部分肾切除术过程中的肿瘤碎裂是否会影响复发?
Int J Clin Oncol. 2019 Jan;24(1):87-93. doi: 10.1007/s10147-018-1331-2. Epub 2018 Aug 6.
10
Surgical Management of Organ-Confined Prostate Cancer with Review of Literature and Evolving Evidence.局限性前列腺癌的外科治疗:文献综述与最新证据
Indian J Surg Oncol. 2018 Jun;9(2):225-231. doi: 10.1007/s13193-016-0594-1. Epub 2017 Jan 13.
前列腺癌根治术后生化复发的定义:标准化定义提案
J Clin Oncol. 2006 Aug 20;24(24):3973-8. doi: 10.1200/JCO.2005.04.0756.
4
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.预测前列腺癌根治术后10年复发概率的术前列线图。
J Natl Cancer Inst. 2006 May 17;98(10):715-7. doi: 10.1093/jnci/djj190.
5
Transcending the volume-outcome relationship in cancer care.超越癌症护理中的容量-结果关系。
J Natl Cancer Inst. 2006 Feb 1;98(3):151-4. doi: 10.1093/jnci/djj055.
6
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.高手术量的前列腺癌根治术后并发症发生率在外科医生之间存在差异:进一步证明技术很重要。
J Urol. 2005 Jun;173(6):2099-103. doi: 10.1097/01.ju.0000158163.21079.66.
7
Surgeon volume and operative mortality in the United States.美国外科医生手术量与手术死亡率
N Engl J Med. 2003 Nov 27;349(22):2117-27. doi: 10.1056/NEJMsa035205.
8
Role of surgeon volume in radical prostatectomy outcomes.外科医生手术量在前列腺癌根治术预后中的作用。
J Clin Oncol. 2003 Feb 1;21(3):401-5. doi: 10.1200/JCO.2003.05.169.
9
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection.医院和外科医生的手术量作为直肠癌切除术后预后的预测因素。
Ann Surg. 2002 Nov;236(5):583-92. doi: 10.1097/00000658-200211000-00008.
10
Variations in morbidity after radical prostatectomy.根治性前列腺切除术后发病率的差异。
N Engl J Med. 2002 Apr 11;346(15):1138-44. doi: 10.1056/NEJMsa011788.